Drug
Dihydroergotamine Mesylate
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Sedation | 308 | 197.4 | 260.3 | signal |
| 2 | Nightmare | 308 | 147.6 | 194.5 | signal |
| 3 | Nephrolithiasis | 222 | 80.5 | 97.4 | signal |
| 4 | Hyperhidrosis | 323 | 41.5 | 55.3 | signal |
| 5 | Extrapyramidal Disorder | 42 | 27.7 | 28.6 | signal |
| 6 | Nasal Congestion | 81 | 22.9 | 24.4 | signal |
| 7 | Ligament Sprain | 12 | 20.1 | 20.3 | signal |
| 8 | Eyelid Ptosis | 12 | 19.5 | 19.7 | signal |
| 9 | Migraine | 105 | 18.3 | 19.9 | signal |
| 10 | Product Use In Unapproved Indication | 262 | 17.7 | 22.1 | signal |
| 11 | Tenderness | 11 | 17.4 | 17.6 | signal |
| 12 | Coordination Abnormal | 13 | 15.3 | 15.4 | signal |
| 13 | Mydriasis | 11 | 14.2 | 14.3 | signal |
| 14 | Ovarian Cyst | 8 | 13.1 | 13.2 | signal |
| 15 | Apathy | 11 | 12.5 | 12.6 | signal |
| 16 | Photophobia | 14 | 12.4 | 12.5 | signal |
| 17 | Meningioma | 11 | 12.3 | 12.4 | signal |
| 18 | Drug Ineffective For Unapproved Indication | 41 | 12.2 | 12.5 | signal |
| 19 | Treatment Failure | 58 | 11.7 | 12.2 | signal |
| 20 | Impaired Quality Of Life | 10 | 11.5 | 11.6 | signal |
| 21 | Sinus Congestion | 9 | 11.0 | 11.1 | signal |
| 22 | Amenorrhoea | 11 | 10.9 | 11.0 | signal |
| 23 | Hypocalcaemia | 11 | 9.6 | 9.7 | signal |
| 24 | Muscle Twitching | 13 | 9.3 | 9.4 | signal |
| 25 | Disability | 11 | 9.2 | 9.3 | signal |
| 26 | Wound Infection | 6 | 9.1 | 9.2 | signal |
| 27 | Upper Limb Fracture | 11 | 9.1 | 9.1 | signal |
| 28 | Diplopia | 14 | 8.9 | 9.0 | signal |
| 29 | Impaired Work Ability | 11 | 8.5 | 8.5 | signal |
| 30 | Drug Effect Less Than Expected | 7 | 8.2 | 8.2 | signal |
| 31 | Limb Discomfort | 14 | 7.5 | 7.5 | signal |
| 32 | Drug Ineffective | 553 | 6.9 | 11.5 | signal |
| 33 | Nervous System Disorder | 13 | 6.9 | 6.9 | signal |
| 34 | Central Nervous System Lesion | 5 | 6.0 | 6.0 | signal |
| 35 | Caesarean Section | 4 | 5.6 | 5.6 | signal |
| 36 | Expired Product Administered | 11 | 5.5 | 5.5 | signal |
| 37 | Crying | 11 | 5.0 | 5.0 | signal |
| 38 | Toxic Skin Eruption | 3 | 4.9 | 4.9 | signal |
| 39 | Product Availability Issue | 5 | 3.7 | 3.7 | signal |
| 40 | Therapeutic Response Shortened | 7 | 3.6 | 3.6 | signal |
| 41 | Withdrawal Syndrome | 9 | 3.5 | 3.5 | signal |
| 42 | Drug Exposure During Pregnancy | 7 | 3.4 | 3.4 | signal |
| 43 | Metrorrhagia | 3 | 2.9 | 2.9 | no signal |